FGV chief executive officer (CEO) Datuk Haris Fadzilah Hassan noted that the group's domestic sales of palm kernel expeller (PKE) and animal feed products increased to 39,000 metric tonnes (MT) in 2020 from 8,000 MT in 2018, with a compound annual growth rate of 121%.

FGV Holdings Bhd has expanded its animal feed and nutrition business by launching a new animal feed brand.

KUALA LUMPUR (March 11): A majority of life insurance companies in the country are extending financial assistance to their policyholders who may develop side effects or complications resulting in hospitalisation from Covid-19 vaccinations.
Life Insurance Association of Malaysia (LIAM) said the coverage includes hospitalisations costs that were medically necessary and reasonable due to side effects from COVID-19 vaccination under the National Covid-19 Immunisation Programme.
A number of life insurance companies are also offering cash relief programme for side effects under their respective Covid-19 vaccine fund or medical assistance programme,” it said in a statement today.
It said the assistance includes reimbursement of medical bills for Covid-19 patients and post Covid-19 vaccination support for hospitalisation due to vaccine side effects; medical assistance and special death benefits; hospitalisation income; and cash relief.
Chief executive officer Mark O’Dell advised policyholders to contact their insurance company to find out more about the assistance offered in the event that they may develop side effects due to the Covid-19 vaccine.
While applauding the government’s proactive efforts to protect the rakyat, he also urged Malaysians to play their part in the COVID-19 battle by registering for the immunisation programme via the MySejahtera application.

KUALA LUMPUR (March 11): A majority of life insurance companies in the country are extending financial assistance to their policyholders who may develop side effects or complications resulting in hospitalisation from Covid-19 vaccinations.
Life Insurance Association of Malaysia (LIAM) said the coverage includes hospitalisations costs that were medically necessary and reasonable due to side effects from COVID-19 vaccination under the National Covid-19 Immunisation Programme.
A number of life insurance companies are also offering cash relief programme for side effects under their respective Covid-19 vaccine fund or medical assistance programme,” it said in a statement today.
It said the assistance includes reimbursement of medical bills for Covid-19 patients and post Covid-19 vaccination support for hospitalisation due to vaccine side effects; medical assistance and special death benefits; hospitalisation income; and cash relief.
Chief executive officer Mark O’Dell advised policyholders to contact their insurance company to find out more about the assistance offered in the event that they may develop side effects due to the Covid-19 vaccine.
While applauding the government’s proactive efforts to protect the rakyat, he also urged Malaysians to play their part in the COVID-19 battle by registering for the immunisation programme via the MySejahtera application.

KUALA LUMPUR (March 11): A majority of life insurance companies in the country are extending financial assistance to their policyholders who may develop side effects or complications resulting in hospitalisation from Covid-19 vaccinations.
Life Insurance Association of Malaysia (LIAM) said the coverage includes hospitalisations costs that were medically necessary and reasonable due to side effects from COVID-19 vaccination under the National Covid-19 Immunisation Programme.
A number of life insurance companies are also offering cash relief programme for side effects under their respective Covid-19 vaccine fund or medical assistance programme,” it said in a statement today.
It said the assistance includes reimbursement of medical bills for Covid-19 patients and post Covid-19 vaccination support for hospitalisation due to vaccine side effects; medical assistance and special death benefits; hospitalisation income; and cash relief.
Chief executive officer Mark O’Dell advised policyholders to contact their insurance company to find out more about the assistance offered in the event that they may develop side effects due to the Covid-19 vaccine.
While applauding the government’s proactive efforts to protect the rakyat, he also urged Malaysians to play their part in the COVID-19 battle by registering for the immunisation programme via the MySejahtera application.

KUALA LUMPUR (March 11): A majority of life insurance companies in the country are extending financial assistance to their policyholders who may develop side effects or complications resulting in hospitalisation from Covid-19 vaccinations.
Life Insurance Association of Malaysia (LIAM) said the coverage includes hospitalisations costs that were medically necessary and reasonable due to side effects from COVID-19 vaccination under the National Covid-19 Immunisation Programme.
A number of life insurance companies are also offering cash relief programme for side effects under their respective Covid-19 vaccine fund or medical assistance programme,” it said in a statement today.
It said the assistance includes reimbursement of medical bills for Covid-19 patients and post Covid-19 vaccination support for hospitalisation due to vaccine side effects; medical assistance and special death benefits; hospitalisation income; and cash relief.
Chief executive officer Mark O’Dell advised policyholders to contact their insurance company to find out more about the assistance offered in the event that they may develop side effects due to the Covid-19 vaccine.
While applauding the government’s proactive efforts to protect the rakyat, he also urged Malaysians to play their part in the COVID-19 battle by registering for the immunisation programme via the MySejahtera application.

The National Covid-19 Immunisation Programme will be implemented in three phases from Feb 24 with the first phase from February to April 2021 for frontline workers involving 500,000 people.

From the screening of temperature to getting the shot takes about 10 to 15 minutes. Even though the observation period is 15 minutes but we need to provide adequate time for monitoring after conducting a simulation exercise for the National Covid-19 Immunisation Programme here today

Health Minister Datuk Seri Dr Adham Baba said the recipient needs to go through five stations: the first station is for screening for symptoms and body temperature, the second station is for registration, the third station for consultation and immunisation agreement, the fourth station is for the actual Covid-19 vaccine jab, and the fifth station is for observation.

Individuals who will be receiving Covid-19 vaccine shots need to go through five stations at a Vaccine Dispensing Centre (PPV), taking about 15 to 30 minutes including monitoring for side effects.

Malaysia Aviation Group’s (MAG) cargo subsidiary MABkargo Sdn Bhd (MASkargo) today successfully flew in the first batch of Covid-19 vaccines to Malaysia.Over 300,000 doses of the Pfizer BioNTech vaccine were transported via a passenger-to-cargo flight utilising the Airbus 330-300 aircraft

DHL Express has successfully delivered the first batch of Covid-19 vaccines to Malaysia.

Solarvest Holdings Bhd inked memorandums of understanding (MoUs) with HLB to be service providers, and to enable accessibility to financing of solar businesses across Malaysia through HLB’s solar photovoltaic financing programme.

Samaiden Group Bhd inked memorandums of understanding (MoUs) with HLB to be service providers, and to enable accessibility to financing of solar businesses across Malaysia through HLB’s solar photovoltaic financing programme.

Employees Provident Fund had acquired 1.58 million shares in Top Glove. These raised the fund's stake in the glove maker to 5.86% or 468.86 million shares.

In the final quarter of last year, Top Glove spent RM1.28 billion on share buy-backs, including RM354.74 million in September, RM802.55 million in November and RM123.5 million in December.

Prior to this month's share buy-backs, Top Glove last purchased its own shares on Dec 14 last year, spending RM3.63 million on buying 576,900 shares.

Topglove raised its net outstanding treasury shares to 202.15 million, equivalent to 2.46%.

Yesterday topgloves it bought 10.11 million shares priced between RM5.78 and RM5.87 per share, according to the group's filing with Bursa Malaysia.

This is the fourth time this month that Top Glove bought back its shares, spending a total of RM141.8 million for the exercise, including RM29.97 million on Feb 19, RM49.27 million on Feb 16 and RM3.69 million on Feb 10.

AmInvestment Bank Research analyst Alex Goh also said in a note today, he has reduced Hibiscus Petroleum's FY21 to FY22 forecast earnings by 7% due to higher non-cash amortization and decommissioning assumptions for the group’s 50%-owned Anasuria concession

Analysts have cut Hibiscus Petroleum Bhd's earnings forecasts after its second quarter (2Q) net profit missed expectations.Public Invest Research’s Nurzulaikha Azali said in a note today, Hibiscus Petroleum's 2Q results make up only 26.4% of her full-year expectations and 55% of consensus.

MARGMA projected the rubber glove annual growth rate demand to reach 15% to 20% with an export revenue of RM34 billion based on global demand that is set to hit 420 billion pieces.

Malaysian Rubber Glove Manufacturers Association (MARGMA), the shortage of rubber gloves globally would continue beyond the first quarter of 2022.

Mohd Redzuan said rubber glove exports contributed 51.1% to the nation’s total exports in October last year compared to 49.1% in the same period in 2019 as demand from foreign countries for rubber gloves increased due to the Covid-19 pandemic.

Minister in the Prime Minister’s Department (Special Functions) Datuk Seri Mohd Redzuan Md Yusof said this was also in line with Malaysia’s status as a major producer of rubber gloves globally with exports valued at RM2.9 billion in October last year.

The government will continue to assist the manufacturing sector, especially the rubber glove industry to maintain Malaysia position as a main player in the supply of rubber gloves for the global health industry.

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?

Post removed.Why?